Literature DB >> 22672791

Effects of flecainide therapy on inappropriate shocks and arrhythmias in catecholaminergic polymorphic ventricular tachycardia.

Caroline Jacquemart1, Fazia Ould Abderrahmane, Martial M Massin.   

Abstract

We report the case of a child with catecholaminergic polymorphic ventricular tachycardia, who had inappropriate electric shocks by an implantable cardioverter defibrillator and from recurrence of arrhythmias despite an appropriate β-blocking treatment. An additional treatment by flecainide completely suppressed inappropriate shocks due to sinusal tachycardia and ventricular tachyarrhythmias. We briefly discuss the potentially interesting effect of flecainide in this specific arrhythmia.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22672791     DOI： 10.1016/j.jelectrocard.2012.05.002

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN： 0022-0736            Impact factor:   1.438


  5 in total

1.  The Role of Flecainide in the Management of Catecholaminergic Polymorphic Ventricular Tachycardia.

Authors:  Krystien Vv Lieve; Arthur A Wilde; Christian van der Werf
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-05

2.  Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry.

Authors:  Thomas M Roston; Jeffrey M Vinocur; Kathleen R Maginot; Saira Mohammed; Jack C Salerno; Susan P Etheridge; Mitchell Cohen; Robert M Hamilton; Andreas Pflaumer; Ronald J Kanter; James E Potts; Martin J LaPage; Kathryn K Collins; Roman A Gebauer; Joel D Temple; Anjan S Batra; Christopher Erickson; Maria Miszczak-Knecht; Peter Kubuš; Yaniv Bar-Cohen; Michal Kantoch; Vincent C Thomas; Gabriele Hessling; Chris Anderson; Ming-Lon Young; Michel Cabrera Ortega; Yung R Lau; Christopher L Johnsrude; Anne Fournier; Prince J Kannankeril; Shubhayan Sanatani
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-02-24

Review 3.  Multiple targets for flecainide action: implications for cardiac arrhythmogenesis.

Authors:  Samantha C Salvage; Karthik H Chandrasekharan; Kamalan Jeevaratnam; Angela F Dulhunty; Andrew J Thompson; Antony P Jackson; Christopher L-H Huang
Journal:  Br J Pharmacol       Date:  2017-05-12       Impact factor: 8.739

4.  Efficacy of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia Is Mutation-Independent but Reduced by Calcium Overload.

Authors:  Hyun Seok Hwang; Marcelo P Baldo; Jose Pindado Rodriguez; Michela Faggioni; Bjorn C Knollmann
Journal:  Front Physiol       Date:  2019-08-13       Impact factor: 4.566

5.  Pooled Analysis of Complications with Transvenous ICD Compared to Subcutaneous ICD in Patients with Catecholaminergic Polymorphic Ventricular Arrhythmia.

Authors:  Henrik Eckert; Ibrahim El-Battrawy; Michael Veith; Gretje Roterberg; Jacqueline Kowitz; Siegfried Lang; Xiaobo Zhou; Ibrahim Akin; Andreas Mügge; Assem Aweimer
Journal:  J Pers Med       Date:  2022-03-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.